- About Us
- Nano-Social Network
- Nano Consulting
- My Account
Platypus Technologies Receives Phase I SBIR for $200k
July 27, 2005
Platypus Technologies has received a Phase I Small Business Innovation Research (SBIR) grant for $200,000 from the National Cancer Institute. The grant is to develop a new liquid-crystal based technology for rapid quantification of protein activity, useful for cancer research.
Platypus Technologies was founded in 2000 to develop nanotechnology products for the physical and life sciences.
About Platypus Technologies:
Platypus Technologies, LLC develops, produces and markets nanotechnologies for the life sciences. We produce a variety of nano-structured surfaces for use in research and are also developing a range of products that derive from a proprietary platform technology using liquid crystals for the rapid detection of molecular interactions. This technology fuses recent advances in nano-scale science, materials science and molecular biology to provide advanced tools for proteomics, cell studies, environmental monitoring and in vitro diagnostics.
Currently, Platypus offers obliquely-deposited gold slides, gold-coated glass slides / mica / silicon wafers / coverslips, optically transparent polyurethane substrates with topography, Functionalization Kits and Contact Printing Kits.
For more information, please visit www.platypustech.com
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017
Nanotubes that build themselves April 14th, 2017